HLS Therapeutics Inc. (HLS.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 110.65M |
| Enterprise Value | 148.68M |
| P/E Ratio | -12.04 |
| PEG Ratio | -0.2 |
| Price/Sales Ratio | 1.76 |
| Price/Book Ratio | 1.97 |
| Enterprise/Revenue | 2.26 |
| Enterprise/EBITDA | 6.93 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.15 |
| Operating Margin | -0.08 |
AD
Management Effectiveness
| Return On Assets | -0.07 |
| Return On Equity | -0.14 |
Income Statement
| Revenue | 56.47M |
| Revenue/Share | 1.66 |
| Gross Profit | 24.01M |
| EBITDA | 18.02M |
| Net Income | -12.65M |
| Diluted EPS | -0.4 |
Balance Sheet
| Total Cash | 13.71M |
| Total Cash/Share | 0.4 |
| Total Debt | 41.84M |
| Total Debt/Equity | 0.76 |
| Current Ratio | 1.05 |
| Book Value Per Share | 1.62 |
Price History
| 52-Week Change | -20.64 |
| 52-Week High | 5.25 |
| 52-Week Low | 0 |
| Moving Average 50 Days | 4.09 |
| Moving Average 200 Days | 4.3 |
Statistics
| Average Volume | 75,961 |
| Shares Outstanding | 30.94M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
